Forum Posts by
- Pharmaceutical Transparency Bills: What’s the Real Purpose?
Posted on April 15, 2016
On Monday, the Massachusetts Joint Committee on Health Care Financing held a hearing on Senate bill 1048, which would require pharmaceutical companies to report to the state a range of information on their research & development costs, marketing and advertising costs, and prices charged to a number of different purchasers. The hearing, recapped by the Boston Globe and Gloucester… Read more
- FDA Proposal for Regulating Laboratory Diagnostics Could Improve Patient Care
Posted on September 4, 2014
Wendy Chung’s commentary last month about the FDA’s proposed draft guidance for the regulation of laboratory-developed tests (LDTs) is heavily critical of the agency’s plans. Professor Chung argues that the FDA’s involvement in this space will have two primary negative consequences: it will stifle innovation and it will harm patient care. But the FDA’s proposal seems designed… Read more